Quarterly report (Form 10-Q)
Bed Bath & Beyond 10-Q for Quarter ended Jun 30, 2026
Filing excerpt
Consolidated cash and cash equivalents decreased from $175.3 million as of December 31, 2025, to $99.5 million as of June 30, 2026, a decrease of $75.8 million, primarily as a result of disbursement for notes receivable of $20.0 million to TBHC, and net cash outflows from operating activities of $50.0 million.